• Recent Advances in Ibuprofen Synthesis for COX Inhibition Re

  2026-07-21

  This review synthesizes the last decade’s progress in the chemical preparation of ibuprofen, emphasizing innovative, practical, and asymmetric approaches. Improved synthetic routes enable greater access to the pharmacologically active (S)-(+)-ibuprofen enantiomer, supporting precise research on inflammation pathways and pain mechanisms.

• Pemetrexed: Multi-Targeted Antifolate for Tumor Research

  2026-07-20

  Pemetrexed is a potent antifolate antimetabolite used as a benchmark in cancer chemotherapy research. It inhibits key folate-dependent enzymes, disrupting nucleotide biosynthesis pathways in tumor cells. Its validated activity in non-small cell lung carcinoma and malignant mesothelioma models underpins its broad utility for studying DNA repair vulnerabilities.

• Metoprolol Tartrate: Precision β1 Blockade in Translational

  2026-07-20

  This thought-leadership article explores the mechanistic selectivity and translational impact of Metoprolol Tartrate as a β1-adrenergic blocking agent. Integrating recent evidence, it provides strategic guidance for cardiovascular and hematopoietic research, underscores the clinical relevance of selective β1-blockade, and offers actionable protocol recommendations. The discussion is anchored by new findings distinguishing β1-selective and nonselective β-blockers, and positions APExBIO’s Metoprolol Tartrate as a gold standard for reproducible, high-impact experimentation.

• U0126: Precision MEK1/2 Inhibitor for MAPK/ERK Pathway Resea

  2026-07-19

  U0126 is a potent, selective MEK1/2 inhibitor widely used to dissect MAPK/ERK signaling. It exhibits sub-100 nM IC50s, robustly suppresses ERK1/2 phosphorylation, and is instrumental in neurobiology and cancer research. Its specific action and solubility properties make it a benchmark tool for signal transduction studies.

• Z-VDVAD-FMK: Precision Caspase-2 Inhibition in Apoptosis Ass

  2026-07-18

  Z-VDVAD-FMK empowers researchers to dissect caspase-2-driven apoptosis and mitochondrial pathways with high specificity, streamlining advanced assay development in both cancer and antiviral research. Its robust cell-permeability, irreversible inhibition, and compatibility with mitochondrial cytochrome c release assays set it apart as a gold-standard tool for mechanistic studies.

• Tauroursodeoxycholic Acid: Elevating ER Stress Research Work

  2026-07-17

  Tauroursodeoxycholic Acid (TUDCA) delivers robust mitochondrial stabilization and anti-apoptotic benefits, making it indispensable for ER stress-related pathology research. This article details actionable protocols, advanced troubleshooting, and translational insights that help labs harness TUDCA’s full potential across neurodegenerative, metabolic, and regenerative medicine models.

• Jiedu Xiaozheng Yin Drives M1 Macrophage Polarization via TL

  2026-07-17

  Liu et al. provide compelling evidence that Jiedu Xiaozheng Yin (JXY), a traditional Chinese medicine formula, suppresses colitis-associated colorectal cancer progression by promoting M1 macrophage polarization through TLR4 signaling. Their integrative use of in vivo and in vitro platforms, including pharmacological pathway antagonists, uncovers actionable immune mechanisms relevant for translational cancer research.

• Trifluoperazine 2HCl: Precision Tools for Dopaminergic and H

  2026-07-16

  Explore how Trifluoperazine 2HCl, a leading dopamine D2 receptor inhibitor, uniquely enables researchers to dissect dopaminergic signaling and macrophage antibacterial responses. This article reveals mechanistic insights and advanced protocols to empower translational neuroscience and immunology.

• Gastroretentive Alfuzosin HCl Sponges: MRI-Based Delivery In

  2026-07-16

  This study introduces a low-density gastroretentive sponge system for Alfuzosin HCl, utilizing a factorial design and MRI monitoring to optimize sustained drug release and enhance gastric retention. The findings offer new directions for improving oral bioavailability and therapeutic targeting in benign prostatic hyperplasia (BPH) research.

• Annexin V, Human Recombinant: Precision Probe for Apoptosis

  2026-07-15

  Annexin V, a phosphatidylserine binding protein, enables specific detection of early apoptosis in cell death research. Supplied by APExBIO, this reagent binds phosphatidylserine exposed on apoptotic cell surfaces and is validated for reproducible, high-sensitivity apoptosis assays. Its application is critical in immunology and cancer research, but correct protocol and interpretation are essential for reliable results.

• Perphenazine: Dopamine D2 Receptor Antagonist for Cell Death

  2026-07-15

  Perphenazine, a robust dopamine D2 receptor antagonist, empowers neuropharmacology and host-pathogen research with its dual capacity for mitochondria-mediated cell death induction and macrophage immunomodulation. This article details hands-on protocols, translational applications, and troubleshooting guidance to maximize reproducibility and innovation in advanced bench workflows.

• Omeprazole (A2845): Technical Protocols for Gastric Acid Stu

  2026-07-14

  Omeprazole (SKU A2845) is a potent H+,K+-ATPase inhibitor designed for research on gastric acid secretion and antiulcer activity in preclinical and in vitro settings. It is not suitable for diagnostic or therapeutic use and should be handled under controlled laboratory protocols to ensure compound integrity and reproducible results.

• Forsythoside E: Mechanistic Leverage for Translational Immun

  2026-07-14

  Forsythoside E, a phenolic acid glycoside from Forsythia suspensa, is redefining how translational researchers tackle sepsis-induced liver injury through precise modulation of immunometabolic pathways. By targeting pyruvate kinase M2 (PKM2) and orchestrating macrophage M2 polarization, Forsythoside E bridges mechanistic clarity and translational promise. This thought-leadership article contextualizes its validated mechanisms, benchmarking protocol guidance and competitive landscape, while advancing a vision for next-generation inflammation research.

• Tiamulin as a Small-Molecule Inhibitor of TNF-α in Psoriasis

  2026-07-13

  A recent study identified Tiamulin (Thiamutilin) as a novel inhibitor of TNF-α, demonstrating its ability to block key inflammatory pathways and alleviate psoriasis-like dermatitis in preclinical models. These findings highlight the potential of repurposing a veterinary antibiotic for inflammatory skin disease research and drug discovery.

• Pertussis Toxin (SKU B7273): Reliable Immune Modulation in C

  2026-07-13

  This article provides an evidence-based exploration of Pertussis toxin (SKU B7273) as a robust AB5-type protein exotoxin for immune modulation studies. It addresses common laboratory challenges in cell viability and cytotoxicity assays, offering practical guidance and scenario-driven insights for biomedical researchers. Emphasis is placed on protocol optimization, data interpretation, and vendor selection to maximize experiment reliability with Pertussis toxin.

456 records 11/31 page Previous Next First page 上5页 1112131415 下5页 Last page